3

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: October 15, 2019
Period of Report: October 15, 2019
Accession Number: 0000886163-19-000184

View Document ↗ View on SEC.gov ↗